BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25267681)

  • 21. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
    Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
    Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol.
    Liu S; Li L; Tan L; Liang X
    Virol Sin; 2019 Jun; 34(3):315-323. PubMed ID: 30915606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
    Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
    BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of sandalwood oil against herpes simplex viruses-1 and -2.
    Benencia F; Courrèges MC
    Phytomedicine; 1999 May; 6(2):119-23. PubMed ID: 10374251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cucumis melo pectin as potential candidate to control herpes simplex virus infection.
    Agostinho KF; Rechenchoski DZ; Faccin-Galhardi LC; de Sousa ALN; Cunha AP; Ricardo NMPS; Linhares REC; Nozawa C
    FEMS Microbiol Lett; 2021 Mar; 368(4):. PubMed ID: 33565598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
    Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
    Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    Andrei G; Gillemot S; Topalis D; Snoeck R
    J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
    Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
    Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
    Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
    Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
    J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic effects of bis(thiosemicarbazone) compounds and its palladium(II) complexes on herpes simplex virus growth.
    Genova P; Varadinova T; Matesanz AI; Marinova D; Souza P
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):107-12. PubMed ID: 15163546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.
    Yamamoto M; Onogi H; Kii I; Yoshida S; Iida K; Sakai H; Abe M; Tsubota T; Ito N; Hosoya T; Hagiwara M
    J Clin Invest; 2014 Aug; 124(8):3479-88. PubMed ID: 25003190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
    Houston DMJ; Bugert JJ; Denyer SP; Heard CM
    PLoS One; 2017; 12(6):e0179291. PubMed ID: 28665969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.